Elos Medtech Interim report, 1 January - 31 March , 2017
(WorldNews Sweden)

o Net sales amounted to SEK 140.9 M (140.4), corresponding to organic growth of 0.4%. Operating profit totalled SEK 13.3 M (12.0). Profit after net financial items amounted to SEK 9.6 M (6.8). Net financial items were negatively impacted by exchange-rate differences of SEK 1.4 M (neg: 1.7). Profit after tax amounted to SEK 7.2 M (4.9), corresponding to SEK 1.19 (0.80) per share. Cash flow was SEK 11.9 M (20.5) from operating activities and SEK 6.6 M (7.0) after investments. CEO Jan Wahlström, comments `The objective of last year`s change efforts was to strengthen Elos Medtech`s position in the market. We already noted in the first quarter that the over haul of the operations, in which we...